Network Recent external collaboration on country level. Dive into details by clicking on the dots.


Photo of Tamara Gray
Photo of Sue Heatley
Photo of David Yeung

Research Output 1999 2018

Efficacy and safety of nilotinib 300 mg twice daily in patients with chronic myeloid leukemia in chronic phase who are intolerant to prior tyrosine kinase inhibitors: Results from the Phase IIIb ENESTswift study

Hiwase, D., Tan, P., D'Rozario, J., Taper, J., Powell, A., Irving, I., Wright, M., Branford, S., Yeung, D. T., Anderson, L., Gervasio, O., Levetan, C., Roberts, W., Solterbeck, A., Traficante, R. & Hughes, T. 1 Apr 2018 In : Leukemia Research. 67, p. 109-115 7 p.

Research output: Research - peer-reviewArticle

Long-term treatment-free remission of chronic myeloid leukemia with falling levels of residual leukemic cells

Ross, D. M., Pagani, I. S., Shanmuganathan, N., Kok, C. H., Seymour, J. F., Mills, A. K., Filshie, R. J., Arthur, C. K., Dang, P., Saunders, V. A., Braley, J., Yong, A. S., Yeung, D. T., White, D. L., Grigg, A. P., Schwarer, A. P., Branford, S., Hughes, T. P. & on behalf of the Australasian Leukaemia and Lymphoma Group (ALLG) 1 Dec 2018 In : Leukemia. 32, 12, p. 2572-2579 8 p.

Research output: Research - peer-reviewArticle